Taxus polysaccharide immunologic adjuvant and influenza vaccine containing same

A technology of yew polysaccharides and immune adjuvants, applied in the field of influenza vaccines, can solve the problems of limited vaccine production and supply, difficulties in meeting infectious diseases, and unavoidable side effects, and achieve weakened activity, high safety, and local swelling of injections obvious effect

Active Publication Date: 2011-08-24
INST OF MEDICAL BIOLOGY CHINESE ACAD OF MEDICAL SCI
View PDF1 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0011] In order to solve many problems such as single immune adjuvant, unavoidable side effects, limited supply of vaccine production, difficulty in meeting the urgent need to provide a large number of vaccines when in

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Taxus polysaccharide immunologic adjuvant and influenza vaccine containing same
  • Taxus polysaccharide immunologic adjuvant and influenza vaccine containing same
  • Taxus polysaccharide immunologic adjuvant and influenza vaccine containing same

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0043] Example 1

[0044] Ethanol Extraction of Taxus chinensis Polysaccharide

[0045] Take 500g of dried Mandia yew branches and leaves, pulverize them into powder, and place them in a container. Use 4 times the volume of 2000 ml ethanol with a concentration of 95% to perform heating and reflux extraction as usual, where each heating temperature is 50°C The reflux time is 60 minutes, and the number of extractions is 2 times. After filtration, the filtrate is decompressed to recover ethanol. After the remaining filtrate is concentrated and dried, 50 grams of ethanol extract is obtained. The paclitaxel content of the extract is 0.2%. The content is more than 60%. Mix the material with 200 mesh silica gel G, load it into a glass chromatography column with an inner diameter of 15 cm and a height of 150 cm. Use methanol and chloroform (the volume ratio of the two is 1:1) as the mobile phase for routine After elution, the yew polysaccharide can be seen brownish-red in the glass column...

Example Embodiment

[0046] Example 2

[0047] Water extraction of yew polysaccharide

Example Embodiment

[0049] Example 3

[0050] Detection of Mandia yew polysaccharides: Take the Mandia yew polysaccharides obtained in Example 1 and Example 2, respectively, according to the method of "The Pharmacopoeia of the People's Republic of China" (2010 edition), page 1008, China Medical Science and Technology Press, High performance liquid chromatography is used for detection, and its indicators meet the requirements of polysaccharides.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Particle sizeaaaaaaaaaa
Login to view more

Abstract

The invention provides a taxus polysaccharide immunologic adjuvant and an influenza vaccine containing the same. The taxus polysaccharide immunologic adjuvant consists of the following components in percentage by mass: 0.001 to 100 percent of taxus polysaccharide and 0 to 99.999 percent of carrier. A mass ratio of the taxus polysaccharide immunologic adjuvant to hemagglutinin of the influenza vaccine is 50 to 183,500. The taxus polysaccharide is a natural substance extracted from branches of taxus; when the taxus polysaccharide is used as the immunologic adjuvant, applicable experiment results are obtained, and the taxus polysaccharide has high safety and small side effect. The influenza vaccine containing the taxus polysaccharide immunologic adjuvant is easy and convenient to prepare, the quality of the vaccine is easy to control, the immunogenicity of the vaccine can be better improved, and the dosage of antigen of the vaccine is greatly reduced; experiments prove that the dosage ofthe antigen of the vaccine, which takes the taxus polysaccharide as the adjuvant, is only half or lower than half of the dosage of the antigen of the vaccine, which takes aluminum hydroxide as the adjuvant, but the immune protective effect is the same.

Description

[0001] technical field [0002] The invention relates to a yew polysaccharide immune adjuvant and an influenza vaccine containing the yew polysaccharide immune adjuvant, belonging to the field of biotechnology. technical background [0003] Mandia yew (Taxus madia) is a natural hybrid variety of yew. Its female parent is Northeast yew (T.cuspidata) and its male parent is European yew (T.bauata). It has grown in the United States and Canada. It has a history of nearly 100 years. my country introduced from Canada in the mid-1990s, and after artificial propagation, it was cultivated in Sichuan, Guangxi, Shandong and Yunnan. Artificially cultivated Mandia yew is an evergreen shrub with huge biomass, short growth time and fast growth speed, the main root is not obvious, but the lateral roots are well developed, and the branches and leaves are lush, strong germination ability, and can withstand -25°C low temperature. Mandia yew has been artificially cultivated and selected, and...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K39/39A61K39/145A61P31/16
Inventor 李映波李慧刘洪卿孙笠雯高天荣
Owner INST OF MEDICAL BIOLOGY CHINESE ACAD OF MEDICAL SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products